Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Shalawate Ayijiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Oxidative Stress, Cyclopropanes, Sulfides, Quinolines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
In response to the US Food and Drug Administration's black box warning highlighting the neuropsychiatric risks associated with montelukast, the mechanisms underlying these psychiatric adverse effects, particularly depression in paediatric populations, have remained poorly understood.
Methods
To address this, we examined whether montelukast induces depression‐like behaviours in an animal model and investigated the potential mechanisms. Young ICR mice were administered montelukast continuously for 28 days, and depression‐like behaviours were assessed using the open field test (OFT), tail suspension test (TST), and forced swim test (FST). Oxidative stress and inflammatory markers were analysed via RT‐qPCR, biochemical assays and western blot.
Results
Our results revealed that 24 h post‐montelukast administration, cysteinyl leukotriene receptor 1 and malondialdehyde (MDA) levels were significantly upregulated in the hippocampus, while glutathione (GSH), glutathione peroxidase 4 (GPx4), superoxide dismutase 2 (SOD2) and catalase (CAT) levels were downregulated. After 28 days of treatment, MDA levels remained elevated, and GSH, GPx4, SOD2 and CAT levels were further reduced. Additionally, hippocampal interleukin‐1β and serum corticosterone levels were increased, whereas hippocampal glucocorticoid receptor expression was decreased.
Conclusions
These findings collectively demonstrate that montelukast induces depression‐like behaviours in young ICR mice through mechanisms involving enhanced oxidative stress and inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
- Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Zengliang Jin
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ayijiang, S., Tiliwaerde, M., Yang, Y., Li, Y., Gao, H., Jia, J., Wang, S., Liu, Q., & Jin, Z. (2025). Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70033
Vancouver
Ayijiang S, Tiliwaerde M, Yang Y, Li Y, Gao H, Jia J, et al. Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70033
BibTeX
@article{Ayijiang2025,
author = {Ayijiang, Shalawate and Tiliwaerde, Murezati and Yang, Yaqi and Li, Yanlin and Gao, Huan and Jia, Jingyi and Wang, Shen and Liu, Qi and Jin, Zengliang},
title = {Montelukast Induces Depressive‐Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70033}
}
EUVIMED